ClinicalTrials.gg
CompletedNCT07293676Updated Oct 28, 2026

IASTM and Vibration Effects on Pain, Functionality, and Kinesiophobia in Lumbar Disc Herniation

An interventional study of Exercise and IASTM in Vibration, Lumbar Disc Herniation and Soft Tissue Mobilization, sponsored by Istanbul Medipol University Hospital. Completed at 1 site in Turkey (Türkiye). Open to participants aged 30 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-28.

Sponsored by Istanbul Medipol University Hospital · Not applicable, Interventional, and Treatment

How we know

Updated Oct 28, 2026Now CompletedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
45
Allocation
Randomized
Ages
30 Years to 60 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 121 studies in Intervertebral Disc Displacement with a site in Turkey — 22 open to participants now, 28 under way, none of them phase 3. Intervertebral Disc Displacement · Turkey.

Enrollment
60th of 86
45 · median 60
Started
2026
with 11 others
No phase
85 of 121
11 open now
Registered
93rd of 121
by date
Lead sponsor
3 of 121
Istanbul Medipol University Hospital

Among the 121 studies in Intervertebral Disc Displacement with a site in Turkey, this one is the 60th largest by enrollment of the 86 interventional ones that give a count, is one of 12 that started in 2026, is one of 85 with no phase, and was the 93rd registered.

Intervertebral Disc Displacement

474 studies on the registry are indexed under Intervertebral Disc Displacement; 98 are open to participants now.

Browse Intervertebral Disc Displacement studies →

Open to participants now

22 of the 121 studies in Intervertebral Disc Displacement with a site in Turkey are open now. Recruiting first, the newest first:

17 more — sign in →

All 22 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 48 Intervertebral Disc Displacement studies recruiting now, 20 (42%) set no upper age limit and 24 (50%) stop at 75 or younger; 3 take children under 18; 6 take healthy volunteers.

This study: 30 Years to 60 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 121 studies in Intervertebral Disc Displacement with a site in Turkey, or all of them as a file.
02

Study summary

The aim of this study is to investigate the effects of Instrument-Assisted Soft Tissue Mobilization and vibration massage therapy on pain, functionality, and kinesiophobia in individuals with lumbar disc herniation.

Read the detailed description

The aim of this study is to investigate the effects of Instrument-Assisted Soft Tissue Mobilization and Percussion massage therapy on pain, functionality, and kinesiophobia in individuals with lumbar disc herniation. In addition, participants will be randomly assigned to three groups Conventional Therapy, Percussion Massage Therapy, and IASTM and the study will aim to examine and compare the pre- and post-treatment effects of these three interventions on pain, functionality, and kinesiophobia.

03

Conditions studied

  • Vibration
  • Lumbar Disc Herniation
  • Soft Tissue Mobilization
04

Who can participate

Ages eligible
30 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Individuals between 30 and 60 years of age
  • Individuals diagnosed with lumbar disc herniation at the protrusion level
  • Individuals with no cognitive, intellectual, or mental impairments and who are able to express themselves
  • Individuals with a VAS score greater than 5
  • Individuals experiencing pain for at least 3 months

Exclusion criteria

Exclusion Criteria:

  • Individuals with a history of lumbar surgery
  • Individuals who are pregnant
  • Individuals who have had a spinal tumor or any other within the past six months
  • Individuals who have received physiotherapy for low back pain within the last six months
  • Individuals with orthopedic conditions such as fractures
  • Individuals diagnosed with neurological, rheumatological, or psychological disorders
  • Individuals with diagnoses such as infection, spondylosis, spondylolysis, osteoporosis, or ankylosing spondylitis will be excluded from the study.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
45 participants (actual)

Study arms

  • Active comparator
    Conventional exercise group

    The exercise program will be performed at home for four weeks, twice daily. Exercise progression will begin with 10 repetitions and will be individualized according to each participant's condition. Exercises that provoke pain will be discontinued as advised. Participants will be provided with an illustrated exercise brochure, and follow-up will be conducted once a week through phone calls. First, participants will be instructed to lie on their backs on a flat surface with their knees bent, placing approximately a 30 cm elevation (such as two pillows) under the calves to assume a relaxation position and maintain it for 30 seconds. The exercise program will include hip flexor and lumbar extensor stretching, hamstring stretching, bridge exercises, erector spinae strengthening (prone superman), quadruped alternating arm-leg raises, and cat-camel exercises.

    Other: Exercise

  • Experimental
    IASTM Group

    Instrument-assisted soft tissue mobilization treatment will be applied twice per week for a total of eight sessions. The intervention will be performed using stainless-steel tools of various sizes specifically designed for different anatomical regions (Figure 2). Instrument-assisted soft tissue mobilization will be administered to the iliocostalis lumborum, erector spinae, and quadratus lumborum muscles, as well as to the superficial and deep fascia. Before the application, a thin layer of petroleum jelly will be applied to the area to facilitate smooth gliding of the instrument. The IASTM treatment will be delivered for a total of six minutes, with each technique (sweep, fan, brush, and sweep) being performed for 8-10 repetitions along the affected muscle fibers.

    Other: Exercise · Other: IASTM

  • Experimental
    Percussion Massage Therapy Group

    Vibration massage therapy will be applied twice per week for a total of eight sessions. After positioning the participant in the prone position, the session will begin. For vibration massage, the No. 2 standard ball attachment of the Theragun™ and the Theragun Pro device, which provides 1750 percussions per minute, will be used. The Theragun will be held perpendicular to the muscle at all times, and no additional pressure other than the weight of the device itself will be applied. Throughout the procedure, the massage gun will be kept in continuous contact with the skin, maintaining consistent pressure. The vibration massage will be administered to the erector spinae and lumbar paravertebral muscle groups. A total of 10 minutes of percussion massage will be applied to the lateral portions of the lower back erector spinae muscles (5 minutes on each side), and the massage gun will be moved in a straight line from the distal to the proximal direction within approximately 30 seconds.

    Other: Exercise · Other: Percussion massage therapy

Interventions

  • OtherExercise

    The exercise program will be performed at home twice daily for a period of four weeks. Participants will begin with 10 repetitions, and the number of repetitions will be individualized based on each person's clinical condition. They will be advised to discontinue any exercises that cause pain. An illustrated exercise brochure will be provided, and weekly follow-up will be conducted through phone calls to ensure adherence. At the start of the program, participants will be instructed to lie supine on a flat surface, bend their knees, and place approximately 30 cm of support (such as two pillows) under their lower legs to achieve a relaxation position, holding it for 30 seconds. The exercise program will include hip flexor and lumbar extensor stretching, hamstring stretching, bridge exercises, erector spinae strengthening in the prone "superman" position, quadruped alternating arm-leg lifts, and cat-camel exercises.

  • OtherIASTM

    Instrument-assisted soft tissue mobilization will be administered twice a week for a total of eight sessions. The treatment will be performed using stainless steel tools of various sizes specifically designed for different anatomical regions. The intervention will target the iliocostalis lumborum, erector spinae, quadratus lumborum muscles, as well as both the superficial and deep fascia. Before beginning the procedure, a thin layer of petroleum jelly will be applied to the skin to ensure smooth gliding of the instrument. During the treatment, instrument-assisted mobilization will be applied over the muscle fibers using the sweep, fan, brush, and sweep techniques, with each technique performed for 8-10 repetitions. The total duration of the application will be six minutes.

  • OtherPercussion massage therapy

    Vibration massage therapy will be administered twice per week for a total of eight sessions. After positioning the participant in the prone position, the treatment session will begin. The vibration massage will be delivered using the Theragun™ device equipped with the No. 2 standard ball attachment, operating at a frequency of 1750 percussions per minute. The device will be held perpendicular to the muscle throughout the application, and no additional pressure other than the weight of the device itself-will be applied. Continuous contact between the massage gun and the skin will be maintained to ensure consistent pressure. The intervention will target the erector spinae and lumbar paravertebral muscles. A total of 10 minutes of percussion massage will be applied to the lateral portions of the lower back, with 5 minutes administered to each side. During the treatment, the device will be guided in a straight path from the distal toward the proximal region within approximately 30 seconds.

06

What researchers measure

Primary outcomes

  1. Visual Analog Scale

    the Visual Analog Scale (VAS) will be used to assess pain intensity. VAS is a widely used tool in daily clinical practice for evaluating pain, and the average pain score ranges from 0 to 10. The VAS is typically defined as a 10-cm horizontal or vertical line that begins with "no pain" and ends with "unbearable pain." This line may be presented as a simple straight line or divided into equal segments. Participants will be asked to mark a point on the line that corresponds to the intensity of their pain. A score of "0" indicates no pain, scores of 1-4 represent mild pain, scores of 5-6 indicate moderate pain, and scores of 7-10 reflect severe pain.

    Time frame: From enrollment to the end of treatment at 4 weeks

  2. Tampa Scale of Kinesiophobia

    The Tampa Scale of Kinesiophobia (TSK) will be used to assess kinesiophobia. This scale is commonly applied in individuals with acute and chronic low back pain, fibromyalgia, and musculoskeletal injuries. The TSK is a 17-item questionnaire developed to measure fear of movement and fear of reinjury, particularly in relation to work-related activities and fear-avoidance behaviors. It uses a 4-point Likert scoring system (1 = Strongly disagree, 4 = Strongly agree). The total score ranges from 17 to 68, with higher scores indicating greater levels of kinesiophobia.

    Time frame: From enrollment to the end of treatment at 4 weeks

  3. The Oswestry Disability Index

    The Oswestry Disability Index (ODI) will be used to assess functional status. The ODI consists of 10 items scored on a scale from 0 to 5 and evaluates pain and limitations in various daily activities in individuals with low back pain. A score of 5 represents the highest level of disability for each item. The maximum possible score is 100%, indicating complete disability. The total score is interpreted across five categories: 0-20% reflects minimal disability, 21-40% indicates moderate disability, 41-60% represents severe disability, 61-80% corresponds to crippled patients, and 81-100% indicates individuals who are bedbound due to their condition.

    Time frame: From enrollment to the end of treatment at 4 weeks

07

Study locations

1 site
  • Istanbul Medipol University
    Istanbul, 34820, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2026 to primary completion in Oct 2026, 9 months.

Of 178 non-industry interventional studies with no phase under Intervertebral Disc Displacement, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 23. This study's 9 months is below that.

Counting every sponsor, half of 191 studies reached it within 12 months; a quarter within 5 and three quarters within 27.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 28, 2026: primary completion May 2026 → Oct 2026 and completion May 2026 → Oct 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Dec 2, 2025
First posted
Dec 19, 2025
StartActual
Jan 5, 2026
Primary completionActual
Oct 26, 2026was May 2026
CompletionActual
Oct 27, 2026was May 2026
Last update
Oct 28, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Oct 28, 2026
Primary completion
May 10, 2026→Oct 26, 2026 (actual)
Oct 28, 2026
Study completion
May 15, 2026→Oct 27, 2026 (actual)
Oct 28, 2026
Show all 1 update
  1. Oct 28, 2026
    Recruiting→Completed
    Primary completion May 10, 2026→Oct 26, 2026 (now actual)
    Study completion May 15, 2026→Oct 27, 2026 (now actual)
    + 3 other changes: verification date, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07293676
Responsible party
burak menek (Principal Investigator, Istanbul Medipol University Hospital) — Principal investigator
First posted
Dec 19, 2025
Start date
Jan 5, 2026
Primary completion
Oct 26, 2026
Completion
Oct 27, 2026
Last update
Oct 28, 2026

Study contacts

Burak Menek
principal investigator · Uludag University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion